$0.8700
-0.00200-0.23%
At close: -
$0.8700
0.000.00%
After Hours: 7:51 PM EDT
Comments
Loading...
Kronos Bio Insider Trading Activity | NASDAQ:KRON | Benzinga
Track the latest Kronos Bio insider trading activity. Stay informed on recent buys, sells, and market impact for Kronos Bio stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Kronos Bio Inc Insiders Doing?
At Kronos Bio Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 24.84K shares worth $21.55K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On June 6, 2025, Deborah Knobelman, the company's PRESIDENT & INTERIM CEO sold 24.84K shares for $0.87 each.
Ownership Statistics for Kronos Bio Inc
Shares Outstanding
60.969M
Insider Shares Owned
5.968M
Insider Percentage Owned
9.79%
Institutional Shares Held
3.803M
Institutional Percentage Held
6.24%
| Jun 06, 2025 | Deborah Knobelman | PRESIDENT & INTERIM CEO | -24.84K | $0.87 | -$21.55K | SELL | -15.12% | 139.42K | Jun 05 | View |
| Jul 01, 2024 | NORBERT BISCHOFBERGER | PRESIDENT & CEO | 615.52K | $1.19 | $733.80K | BUY | 5.89% | 11.07M | Jun 27 - Jun 28 | View |
| Jun 12, 2024 | Norbert W Bischofberger | PRESIDENT & CEO | 3.01M | $1.04 | $3.12M | BUY | 64.85% | 7.64M | Jun 10 - Jun 12 | View |
| Feb 23, 2024 | Elizabeth Olek | SR VP, CLINICAL SCIENCE | -7.37K | $1.05 | -$7.77K | SELL | -3.67% | 193.28K | Feb 21 | View |
| Feb 23, 2024 | Charles Lin | SR VP, RESEARCH & DEVELOPMENT | -12.04K | $1.05 | -$12.68K | SELL | -4.88% | 234.60K | Feb 21 | View |
| Feb 23, 2024 | Allison Frisbee | SR VP, CORP OPERATIONS & LEGAL | -12.11K | $1.05 | -$12.76K | SELL | -5.59% | 204.51K | Feb 21 | View |
| Jan 05, 2024 | Christopher Dinsmore | CHIEF SCIENTIFIC OFFICER | -7.37K | $1.18 | -$8.72K | SELL | -2.75% | 260.97K | Jan 04 | View |
| Jan 05, 2024 | Jorge DiMartino | CHIEF MEDICAL OFFICER & VP | -12.01K | $1.18 | -$14.21K | SELL | -3.67% | 315.25K | Jan 04 | View |
| Jan 05, 2024 | Barbara Kosacz | COO & GENERAL COUNSEL | -10.68K | $1.18 | -$12.64K | SELL | -1.14% | 928.97K | Jan 04 | View |
| Dec 13, 2023 | Christopher Dinsmore | CHIEF SCIENTIFIC OFFICER | -10.03K | $1.30 | -$13.09K | SELL | -3.60% | 268.33K | Dec 12 | View |
| Dec 13, 2023 | Jorge DiMartino | CHIEF MEDICAL OFFICER & VP | -17.37K | $1.30 | -$22.66K | SELL | -5.04% | 327.25K | Dec 12 | View |
| Nov 17, 2023 | NORBERT BISCHOFBERGER | PRESIDENT & CEO | 1.73M | $0.85 | $1.47M | BUY | 161.27% | 2.80M | Nov 15 - Nov 17 | View |
| Jul 07, 2023 | Christopher Dinsmore | CHIEF SCIENTIFIC OFFICER | -6.63K | $1.75 | -$11.62K | SELL | -2.33% | 278.37K | Jul 06 | View |
| Jul 07, 2023 | Jorge DiMartino | CHIEF MEDICAL OFFICER & VP | -10.82K | $1.75 | -$18.96K | SELL | -3.04% | 344.62K | Jul 06 | View |
| Jul 07, 2023 | Yasir AlWakeel | CHIEF FINANCIAL OFFICER | -9.62K | $1.75 | -$16.85K | SELL | -2.70% | 346.10K | Jul 06 | View |
| Feb 24, 2023 | Christopher Dinsmore | CHIEF SCIENTIFIC OFFICER | -6.29K | $1.74 | -$10.92K | SELL | -2.16% | 285.00K | Feb 24 | View |
| Feb 24, 2023 | Jorge DiMartino | CHIEF MEDICAL OFFICER & VP | -10.15K | $1.74 | -$17.62K | SELL | -2.78% | 355.44K | Feb 24 | View |
| Feb 24, 2023 | Yasir AlWakeel | CHIEF FINANCIAL OFFICER | -9.03K | $1.74 | -$15.66K | SELL | -2.47% | 355.72K | Feb 24 | View |
| Dec 14, 2022 | Jorge DiMartino | CHIEF MEDICAL OFFICER & VP | -18.66K | $1.81 | -$33.68K | SELL | -7.83% | 219.48K | Dec 12 | View |
| Dec 14, 2022 | Christopher Dinsmore | CHIEF SCIENTIFIC OFFICER | -9.14K | $1.81 | -$16.50K | SELL | -5.31% | 162.94K | Dec 12 | View |
| May 19, 2022 | NORBERT BISCHOFBERGER | PRESIDENT & CEO | 597.13K | $3.77 | $2.25M | BUY | 125.39% | 1.07M | May 17 - May 19 | View |
| Dec 15, 2021 | Christopher Dinsmore | CHIEF SCIENTIFIC OFFICER | -11.39K | $12.37 | -$140.84K | SELL | -11.82% | 84.97K | Dec 13 | View |
| Dec 15, 2021 | Jorge DiMartino | CHIEF MEDICAL OFFICER & VP | -16.40K | $12.37 | -$202.89K | SELL | -12.25% | 117.53K | Dec 13 | View |
| Dec 08, 2021 | NORBERT BISCHOFBERGER | PRESIDENT & CEO | 14.36K | $12.09 | $173.49K | BUY | 3.11% | 476.23K | Dec 06 | View |
| Dec 02, 2021 | Marianne Backer De | DIRECTOR | 1.15K | $11.57 | $13.31K | BUY | 71.88% | 2.75K | Dec 01 | View |
| Oct 04, 2021 | Christopher Dinsmore | CHIEF SCIENTIFIC OFFICER | 0.00 | $12.04 | -$161.15K | SELL-OPTIONS | 0.00% | 96.36K | Oct 04 | View |
| Sep 09, 2021 | Christopher Dinsmore | CHIEF SCIENTIFIC OFFICER | 0.00 | $12.59 | -$171.25K | SELL-OPTIONS | 0.00% | 96.36K | Sep 07 | View |
| Aug 24, 2021 | Marianne Backer De | DIRECTOR | 1.00K | $19.57 | $19.57K | BUY | 166.67% | 1.60K | Aug 20 | View |
| Aug 03, 2021 | Christopher Dinsmore | CHIEF SCIENTIFIC OFFICER | 0.00 | $11.93 | -$159.12K | SELL-OPTIONS | 0.00% | 96.36K | Aug 02 | View |
| Jun 01, 2021 | Marianne Backer De | DIRECTOR | 600.00 | $25.01 | $15.01K | BUY | ∞ | 600.00 | May 28 | View |
| Apr 20, 2021 | Jakob Loven | DIRECTOR | -68.72K | $20.64 | -$1.42M | SELL | -5.01% | 1.30M | Apr 16 - Apr 20 | View |
| Apr 15, 2021 | Jakob Loven | DIRECTOR | -74.47K | $22.70 | -$1.69M | SELL | -5.15% | 1.37M | Apr 13 - Apr 15 | View |
| Apr 12, 2021 | Jakob Loven | DIRECTOR | -100.62K | $27.19 | -$2.74M | SELL | -6.51% | 1.44M | Apr 08 - Apr 12 | View |
| Oct 16, 2020 | Omega Fund V LPOmega Fund V GP LPOmega Fund V GP Manager LtdAnneMari PasterClaudio NessiOtello Stampacchia | — | 3.80M | $17.72 | $14.47M | DERIVATIVE CONVERSION | 19530.27% | 3.82M | Oct 14 | View |
| Oct 16, 2020 | Otello Stampacchia | — | 3.80M | $17.72 | $14.47M | DERIVATIVE CONVERSION | 19530.27% | 3.82M | Oct 14 | View |
| Oct 16, 2020 | Elena Ridloff | — | 2.63K | $19.00 | $49.97K | PURCHASE | ∞ | 2.63K | Oct 14 | View |
| Oct 16, 2020 | JOHN MARTIN | — | 1.95M | $16.92 | $4.76M | DERIVATIVE CONVERSION | ∞ | 1.95M | Oct 14 | View |
| Oct 16, 2020 | Barbara Kosacz | — | 5.25K | $19.00 | $99.75K | PURCHASE | 0.86% | 614.60K | Oct 14 | View |
| Oct 16, 2020 | Christopher Dinsmore | — | 5.25K | $19.00 | $99.75K | PURCHASE | ∞ | 5.25K | Oct 14 | View |
| Oct 16, 2020 | Yasir AlWakeel | — | 5.25K | $19.00 | $99.75K | PURCHASE | 16.42% | 37.22K | Oct 14 | View |
| Oct 16, 2020 | Trust Vivos Inter Revocable Inger Norbert Bischofberger | — | 2.25M | $17.12 | $4.81M | DERIVATIVE CONVERSION | 106.04% | 4.37M | Oct 14 | View |
| Oct 16, 2020 | NORBERT BISCHOFBERGER | — | 3.30M | $17.12 | $4.81M | DERIVATIVE CONVERSION | ∞ | 263.75K | Oct 14 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
